ASR Dutch Science Park Fund has expanded its portfolio by acquiring Avery Dennison’s European HQ in Leiden Bio Science Park from LCN Capital Partners.
Financial details were not disclosed.
The acquisition marks the fund’s entry into Leiden Bio Science Park, adding to its existing holdings at TU Delft Campus South, Biotech Campus Delft, and Kennispark Twente.
The ASR Dutch Science Park Fund has exclusive partnerships with the three Dutch science parks to support their further development.
The Avery Dennison building, a modern and sustainable office and laboratory facility, will continue to be occupied by the global materials science company.
Martin Kraaij, fund director of ASR Dutch Science Park Fund, said: ‘This acquisition is in line with our fund strategy to expand and diversify our portfolio to different science parks. Leiden Bio Science Park is one of the 19 science parks in the Netherlands where the fund wants to invest and was at the top of our wish list. The acquisition of this sustainable building is a great addition to our portfolio.’
Designed by Paul de Ruiter Architects and developed by OVG (Edge Technologies), the six-storey, 12,154 m2 building has an AA++ energy label and BREEAM Very Good rating. Amenities include a restaurant and meeting areas, upper floors with office and lab space, and a parking garage with charging stations.
The Leiden Bio Science Park is located in Oegstgeest, near the A44 highway, and is home to a number of top-tier educational institutions, research facilities, and healthcare organisations.
NL Real Estate | Knight Frank represented a.s.r. real estate and the ASR Dutch Science Park Fund in the acquisition, while CBRE advised the seller, LCN Capital Partners.
The ASR Dutch Science Park Fund primarily targets institutional investors, with ASR Nederland NV as its main investor.